Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 122Squamous Cell Carcinoma of Head and Neck 60Melanoma 57Parkinson Disease 4, Autosomal Dominant Lewy Body 47Lung Neoplasms 46Triple Negative Breast Neoplasms 44Neoplasm Metastasis 44Breast Neoplasms 40Neoplasms 38Colorectal Neoplasms 33Head and Neck Neoplasms 27Carcinoma, Renal Cell 27Endometrial Neoplasms 26Carcinoma, Transitional Cell 24Ovarian Neoplasms 23Urinary Bladder Neoplasms 21Stomach Neoplasms 16Carcinoma 15Pancreatic Neoplasms 14Uterine Cervical Neoplasms 12Recurrence 12Esophageal Neoplasms 12Sarcoma 11Hodgkin Disease 11Brain Neoplasms 11Cholangiocarcinoma 10Carcinoma, Squamous Cell 10Carcinoma, Hepatocellular 9Skin Neoplasms 8Prostatic Neoplasms 8

Interventions

pembrolizumab 1osimertinib 1durvalumab 1AZD 6244 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Non Small Cell Lung Cancer × pembrolizumab × 90 days × Clear all
NCT05777603 2026-04-09

Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
23 enrolled
Thoracic

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡